Year Ended September 30,

2025

2024

2023

Numerator:

Net income attributable to Amdocs Limited

$

564,704

$

493,197

$

540,709

Net income and dividends attributable to participating restricted stock

(10,590

)

(9,338

)

(9,169

)

Numerator for basic earnings per ordinary share

$

554,114

$

483,859

$

531,540

Undistributed income allocated to participating restricted stock

6,296

5,245

5,719

Undistributed income reallocated to participating restricted stock

(6,262

)

(5,215

)

(5,679

)

Numerator for diluted earnings per ordinary share

$

554,148

$

483,889

$

531,580

Denominator:

Weighted average number of shares outstanding - basic

111,147

115,489

119,687

Weighted average number of participating restricted stock

(2,084

)

(2,187

)

(2,030

)

Weighted average number of ordinary shares - basic

109,063

113,302

117,657

Effect of dilutive equity-based compensation awards

599

656

832

Weighted average number of ordinary shares - diluted

109,662

113,958

118,489

Basic earnings per ordinary share attributable to Amdocs Limited

$

5.08

$

4.27

$

4.52

Diluted earnings per ordinary share attributable to Amdocs Limited

$

5.05

$

4.25

$

4.49